Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel

about

Pharmacodynamic interplay of the P2Y(1), P2Y(12), and TxA(2) pathways in platelets: the potential of triple antiplatelet therapy with P2Y(1) receptor antagonism Recent progress and market analysis of anticoagulant drugs.

P2860

Q36532804-1FCEB32F-7A23-45A7-BB82-D976CFE78A76 Q55072550-345D4F9D-DD0B-4C24-A149-02433260F8B3

P2860

Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel

Item

http://www.wikidata.org/entity/Q36153265

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@ast

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@en

type

Item

label

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@ast

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@en

prefLabel

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@ast

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@en

P1476

Effects of P2Y(1) receptor an ...... using aspirin and clopidogrel

@en

P2093

A Bonnefoy

http://www.w3.org/2001/XMLSchema#string

B Labarthe

http://www.w3.org/2001/XMLSchema#string

J Babin

http://www.w3.org/2001/XMLSchema#string

P Théroux

http://www.w3.org/2001/XMLSchema#string

P2860

Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis

The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented

Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug

Effect of increasing doses of aspirin on platelet aggregation among stroke patients

P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation

Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease

Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques

Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.

Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice

The platelet P2 receptors in thrombosis.

P304

221-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01683.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Marijke Bryckaert

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51676566

http://www.w3.org/2001/XMLSchema#string

P698

21950486

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

3415650

http://www.w3.org/2001/XMLSchema#string

Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel

about

P2860

P2860

Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932